throbber
Metl1ods'in.Molecular Biology o 8'
`
`Practical
`
`Molecular Virology
`
`Viral Vectors for Gene Expression
`
`Edited by
`
`Mary K. L. Collins
`
`Chester Beatty Laboratories, Institute of Cancer Research,
`London, UK
`
`\ /
`‘j, C" Humana Press 0 Clifton, New Jersey
`
`MERCK v. GENENTECH
`MERCK V. GENENTECH
`IPR2016-01373
`IPR2016-01373
`GENENTECH 2031
`GENENTECH 2031
`
`

`
`

`
`(cid:3) (cid:55)(cid:75)(cid:76)(cid:86)(cid:3)(cid:80)(cid:68)(cid:87)(cid:72)(cid:85)(cid:76)(cid:68)(cid:79)(cid:3)(cid:80)(cid:68)(cid:92)(cid:3)(cid:69)(cid:72)(cid:3)(cid:83)(cid:85)(cid:82)(cid:87)(cid:72)(cid:70)(cid:87)(cid:72)(cid:71)(cid:3)(cid:69)(cid:92)(cid:3)(cid:38)(cid:82)(cid:83)(cid:92)(cid:85)(cid:76)(cid:74)(cid:75)(cid:87)(cid:3)(cid:79)(cid:68)(cid:90)(cid:3)(cid:11)(cid:55)(cid:76)(cid:87)(cid:79)(cid:72)(cid:3)(cid:20)(cid:26)(cid:3)(cid:56)(cid:17)(cid:54)(cid:17)(cid:3)(cid:38)(cid:82)(cid:71)(cid:72)(cid:12)(cid:3)
`This material may be protected by Copyright law (Title 17 U.S. Code)
`
`CHAPTER 5
`
`Selectable Markers
`
`for Eukaryotic Cells
`
`Richard Vile
`
`1. Introduction
`
`The transfer of DNA sequences into a population of cells can rarely, if
`ever, be achieved with 100% efliciency. Typically, transfection of cells with the
`calcium phosphate method will transduce only between 0.1 and 1% of the
`cells with the sequences of interest (1), although some workers have achieved
`higher efficiencies (2). If the transferred sequences do not confer a selective
`growth advantage, it is essential to use selection for transduced cells. The
`marker gene itselfmay be the gene of interest, e.g., to label a certain cellular
`population; alternatively, expression of the marker may merely be a convenient
`selection for the cellular population expressing another gene that has been
`cotransfected with the marker. Critically, selectable markers permit positive
`selection (i.e., the cells ofinterest are not killed); this is in contrast to systems in
`which demonstration of infection with a virus leads to death of the recipient
`cell (such as VSV pseudotypes, see Chapter 9).
`
`1.1 . Types ofSelectable Markers
`1.1.1. Dominant Selectable Markers
`
`Many dominant selectable markers are bacterial genes that can be ex-
`pressed in eukaryotic cells when placed under the control of suitable pro-
`moter elements. The recipient cells do not have to posses specific genotypes.
`
`From: Methods in Molecular Biology, Vol. 8:
`Practical Molecular Virology: Viral Vectors for Gene Expression
`Edited by: M. Collins © 1991 The Humana Press Inc., Clifton. NJ
`
`49
`
`

`
`

`
`

`
`

`
`

`
`

`
`

`
`56
`
`-
`
`Vile
`
`24-multiwell plate, to grow in a range of concentrations of the drug. (For
`cells in suspension, 10‘ cells in 100 },lL should be plated in 96-well plates.)
`The optimal concentration to be used for selection is generally determined
`to be the lowest concentration that kills all the cells within 10-14 days, although
`some antibiotics can kill cells faster than this, so the dying cells should be
`continually monitored. The selective medium should be changed every 2-3
`days during this period to remove dead and dying cells. As stated earlier, it is
`not possible to quote definitive concentrations for any selection system, since
`this depends on the cell type used, the construct from which the marker is
`expressed, and the growth conditions.
`
`.
`
`3.2. Time-Course
`
`for DNA Zhansfer and Subsequent Selection
`
`A typical experimental protocol for the transformation of adherent test
`cells to antibiotic resistance is described below.
`
`1. Plate 5 X 105 cells in a 90—mm plate.
`2. After 16-24 h, transfer DNA into the cells using the method of choice
`(calcium phosphate precipitation, lipofection, electroporation, DEAE
`dextran, or viral infection). The marker gene is included either by itself
`(~15 ug), as cotransfected plasmid (~0.5 pg), or as an integral compo-
`nent of the test DNA sequences.
`3. Leave the transformed cells at least 36-48 h to grow in normal medium.
`This allows the integration and expression of the transferred sequences,
`and the accumulation of the enzymes required to degrade the antibiotic.
`4. Split the cells into the appropriate selection medium. The strength of
`the split depends on the efficiency of the transfer process and, also on
`the optimal cell density requirements for the selection. Typically, 5 x 10‘
`cells are plated into selection medium per 90-mm plate.
`5. Grow the selecting cells for up to 14 d by removing dying cells every 341 ~
`(1 and renewing the selection medium. Separate colonies should become
`visible on the bottom of the plate, which can be cloned using cloning
`rings and expanded for further study.
`
`3.3. Selection for Gene Amplification
`
`Selection for gene amplification frequently requires specific growth media
`for the recipient cells, especially if the amplification is sought after introduc-
`tion of the marker gene into a cell deficient in endogenous activity of the
`gene. Details of these requirements are given in ref. 14. Otherwise, transfec-

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket